Navigation Links
Haemonetics Sets Date for Investor/Analyst Meeting
Date:4/24/2013

BRAINTREE, Mass., April 24, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst meeting on Thursday, May 16th from 10:00 am to 3:00 pm at The Seaport Hotel in Boston, Massachusetts.

(Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO)

The agenda for the meeting includes updates on the following:

  • Hospital Based Blood Management Solutions / Emerging Markets
  • R&D Update Including Automated Whole Blood, OrthoPAT® Advance™ and Future New Products
  • Commercial Value Creation & Capture (" VCC")
  • Operations Overview and Strategy
  • Guidance and Aspirational Goals

The meeting is open to analysts, shareholders, and others in the investment community by invitation. Invitations will follow shortly and attendees must register by May 3rd. On-line registration will be utilized and instructions for registration will accompany invitations.

Other audiences are welcome to participate in the meeting via live webcast. Webcast details are posted on the following link:  http://www.media-server.com/m/p/64xj58en.  For more information, please contact Bryanne Salmon at (781) 356-9613 or bsalmon@haemonetics.com.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT: Investor Relations
Gerry Gould (781) 356-9402
gerry.gould@haemonetics.com
Bryanne Salmon (781) 356-9613                                                                                                 bsalmon@haemonetics.com  


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
2. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
3. Haemonetics Completes Acquisition of Palls Transfusion Medicine Business
4. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
5. Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
6. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
7. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
8. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
9. Stereotaxis Epoch™ Solutions Momentum Drives Strong Presence at the Heart Rhythm Society (HRS) Annual Meeting
10. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
11. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/15/2017)... , July 15, 2017 Enterin Inc., a ... to treat Parkinson,s disease (PD), today announced the completion of ... new investors New Ventures III, as well as the participation ... are absolutely thrilled to have the support of New Ventures ... our investors as validation of the potential of our platform ...
(Date:7/14/2017)... 13, 2017 It should come as no surprise ... is in the midst of a crippling opioid epidemic. According ... the number of overdose deaths from opiate-based medications has quadrupled, ... a million dead from 2001 to 2015". During this time, ... has similarly quadrupled, drawing a compelling link between prescription and ...
(Date:7/13/2017)... Calif. , July 13, 2017 RK Logistics ... Board of Pharmacy certification for its Fremont, CA ... support solutions in the Tri-Valley and San Jose ... City of Fremont , with its Fremont ... Group to provide such a powerful resource to the hundreds ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... July 24, 2017 , ... Cheerag D. Upadhyaya , ... Marion Bloch Neuroscience Institute (SLMBNI), part of Saint Luke’s Health System . ... , Cheerag D. Upadhyaya, MD. M.Sc., FAANS joins Stanley P. Fisher, M.D., ...
(Date:7/24/2017)... ... July 24, 2017 , ... Horizon Goodwill Industries, ... unique opportunity that helps high school girls succeed in STEM programs as well ... Horizon Goodwill will host over 20 high school girls at their corporate headquarters ...
(Date:7/24/2017)... ... , ... Every year, thousands of dedicated Higher Education and K12 professionals flock ... coupled with a dynamic theme like Camp Canvas; this year, they’ve managed to take ... , To extend their partnership with Canvas beyond the LMS integration, Modo Labs secured ...
(Date:7/24/2017)... ... July 24, 2017 , ... A CDC study shows that, although people are taking more ... 18 to 29), had at least one case of sunburn within the past year. It’s ... people to ignore the issue. However, only recently have people become conscientious of the risks ...
(Date:7/24/2017)... ... , ... Sharon Kleyne, host of the nationally syndicated The Sharon Kleyne Hour ... Tears® EyeMist® recently talked on the air about an alarming Post magazine article of ... Zidor Aldama described the situation in which Chinese children are under pressure to perform ...
Breaking Medicine News(10 mins):